Dynamic Technology Lab Private Ltd bought a new position in agilon health, inc. (NYSE:AGL – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 41,968 shares of the company’s stock, valued at approximately $526,000.
A number of other hedge funds have also recently added to or reduced their stakes in the stock. Norges Bank acquired a new stake in shares of agilon health in the fourth quarter valued at approximately $27,902,000. Brown Advisory Inc. increased its position in agilon health by 2.9% during the 4th quarter. Brown Advisory Inc. now owns 4,086,411 shares of the company’s stock valued at $51,284,000 after purchasing an additional 116,681 shares during the period. Checchi Capital Advisers LLC boosted its holdings in shares of agilon health by 1.0% during the 4th quarter. Checchi Capital Advisers LLC now owns 257,537 shares of the company’s stock worth $3,232,000 after buying an additional 2,475 shares in the last quarter. Qsemble Capital Management LP bought a new position in shares of agilon health in the 4th quarter worth $158,000. Finally, AGF Management Ltd. purchased a new stake in shares of agilon health during the 4th quarter valued at $3,057,000.
Analyst Ratings Changes
A number of analysts recently weighed in on AGL shares. Evercore ISI dropped their target price on agilon health from $7.00 to $6.00 and set an “in-line” rating for the company in a research report on Wednesday, February 28th. Truist Financial increased their price target on agilon health from $6.40 to $6.50 and gave the company a “hold” rating in a research note on Friday. Jefferies Financial Group restated a “hold” rating and set a $6.50 price objective (down from $25.00) on shares of agilon health in a report on Monday, February 26th. Citigroup started coverage on shares of agilon health in a research report on Monday, April 22nd. They set a “neutral” rating and a $6.00 target price for the company. Finally, TD Cowen lowered agilon health from an “outperform” rating to a “market perform” rating and cut their price objective for the stock from $12.00 to $6.50 in a research note on Monday, February 26th. One analyst has rated the stock with a sell rating, twelve have issued a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $9.25.
View Our Latest Stock Report on AGL
agilon health Trading Up 7.9 %
Shares of NYSE:AGL opened at $6.10 on Friday. agilon health, inc. has a one year low of $4.41 and a one year high of $21.52. The company has a 50 day moving average of $5.26 and a 200-day moving average of $7.74. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.04.
agilon health (NYSE:AGL – Get Free Report) last released its quarterly earnings results on Tuesday, February 27th. The company reported ($0.41) earnings per share for the quarter, missing the consensus estimate of ($0.28) by ($0.13). The company had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.02 billion. agilon health had a negative net margin of 5.67% and a negative return on equity of 26.15%. The firm’s quarterly revenue was up 71.8% compared to the same quarter last year. During the same quarter last year, the company earned ($0.14) EPS. On average, sell-side analysts anticipate that agilon health, inc. will post -0.35 EPS for the current fiscal year.
agilon health Company Profile
(Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Further Reading
Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGL – Free Report).
Receive News & Ratings for agilon health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for agilon health and related companies with MarketBeat.com’s FREE daily email newsletter.